Antibiotics

Daniel Diekema, MD, explains why microbiology labs should be seen as an integral part of antimicrobial stewardship efforts.

According to a recent dispatch from the Centers for Disease Control and Prevention, a drug-resistant strain of Neisseria gonorrhoeae was found in Canada this year.

In a new study, researchers have learned more about a toxin produced by an E. coli strain to communicate with neighboring bacteria.

James S. Lewis, PharmD, FIDSA, discusses the role vaccination plays in reducing unnecessary antibiotic use.

What microbial growth was found after Contagion® writer, Saskia Popescu swabbed & sent her samples?

Researchers are gaining a greater understanding of the role that human genetics plays in determining who contracts tuberculosis as well as how severely it impacts its victims.

A recent study seeks to determine if the combination of minocycline with colistin could decrease the incidence of acute renal failure in those treated.

Norman B. Javitt, MD, PhD, explains how antibiotics can impact bile acid composition and result in Clostridium difficile infection.

Joe Sliman, MD, MPH, explains how antibiotics affect the gut microbiome.

A new study suggests that village clinics are not properly dealing with the ongoing problem of tuberculosis in rural China.

Glenn Tillotson, PhD, FIDSA, discusses the societal value of antibiotics.

Stuart Johnson, MD, discusses the disadvantages to some of the current approaches used to treat C. difficile.

Edmond Hooker, MD, DrPH, discusses multiple factors that put patients at increased risk of getting C. difficile.

An examination of broad-spectrum antibiotic use in this patient population is essential for developing strategies to mitigate the risk of these infections.

James S. Lewis, PharmD, FIDSA, discusses the need for the development of non-antibacterial options against infections, such as monoclonal antibodies.

Daniel Diekema, MD, explains how the microbiology lab works to provide optimal drug selection for empiric and directed therapy.